KINSTON CUMMINGS: Open Payments
NPI 1295462778 · LAKEPORT, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$639 in 19 payments from 8 companies in 2025. Trend: 2023 $1,362 · 2024 $1,529 · 2025 $639
Food & beverage: $639
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 6 | $235 |
| Galderma Laboratories, L.P. | 2 | $148 |
| Janssen Biotech, Inc. | 3 | $89 |
| Novartis Pharmaceuticals Corporation | 3 | $61 |
| UCB, Inc. | 2 | $45 |
| ABBVIE INC. | 1 | $25 |
| GENZYME CORPORATION | 1 | $20 |
| Arcutis Biotherapeutics, Inc. | 1 | $16 |
Products named: OPZELURA, TREMFYA, Bimzelx, RINVOQ, COSENTYX, DUPIXENT, Rhapsido, Zoryve.
Industry payments across CA — which companies pay providers there.
